EMVision Medical Devices Secures AU$1.2 Million IGP Grant After First Responder Milestone

MT Newswires Live
05/25

EMVision Medical Devices (ASX:EMV) has confirmed that it has met the required progress under its first responder program, triggering the next grant instalment of AU$1.2 million from the Australian Government's industry growth program (IGP), which is expected to be received in May, according to a Monday filing with the Australian bourse.

The funding forms part of a AU$5 million non-dilutive grant awarded in June 2025 to support the commercialization of its first responder brain scanner, a portable device intended for pre-hospital use in emergency road and aeromedical settings, per the filing.

Payments are disbursed quarterly in advance, subject to eligible spending and milestone delivery, with the company having received AU$1 million so far and AU$2.8 million remaining under the grant facility, the filing added.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10